Incyte INCY
NASDAQ INCY
$115.30 -1.84 (-1.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Incyte (INCY) Non Operating Interest Expenses (2010 - 2026)

Updated

Incyte's Non Operating Interest Expenses came in at $582,000 for Q2 2026, down 2.0% from $594,000 a year earlier but up 2.3% from the prior quarter.

Analysis

Incyte (INCY) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Incyte reported Non Operating Interest Expenses of $2.33 million, down 5.0% year-over-year; for FY2025, it was $2.43 million, up 6.5% from FY2024.

  • Non Operating Interest Expenses carries a five-year compound annual growth rate of 2.2% (FY2020 to FY2025).
  • Going back by year, Non Operating Interest Expenses was $2.28 million in FY2024 (-10.6%), $2.55 million in FY2023 (-4.3%), $2.67 million in FY2022 (+39.7%) and $1.91 million in FY2021 (-12.2%).
  • The five-year range for quarterly Non Operating Interest Expenses is $419,000 (Q4 2024) to $804,000 (Q4 2023).
  • Year-over-year, Non Operating Interest Expenses increased in three of the last eight quarters, with growth averaging 2.5%.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q1 2022 (growth of 89.4%), and the weakest in Q4 2024 (a decline of 47.9%).
  • Business Quant data shows INCY's Non Operating Interest Expenses at $569,000 (Q1 2026), $582,000 (Q4 2025) and $592,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Incyte 23.54 Bn 8.48 Bn 1.57 Bn 582,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 582,000.00
Mar 31, 2026 569,000.00
Dec 31, 2025 582,000.00
Sep 30, 2025 592,000.00
Jun 30, 2025 594,000.00
Mar 31, 2025 660,000.00
Dec 31, 2024 419,000.00
Sep 30, 2024 774,000.00
Jun 30, 2024 657,000.00
Mar 31, 2024 430,000.00
Dec 31, 2023 804,000.00
Sep 30, 2023 623,000.00
Jun 30, 2023 655,000.00
Mar 31, 2023 469,000.00
Dec 31, 2022 667,000.00
Sep 30, 2022 641,000.00
Jun 30, 2022 678,000.00
Mar 31, 2022 680,000.00
Dec 31, 2021 752,000.00
Sep 30, 2021 439,000.00
API Access

Incyte Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=INCY&period=max&api_key=YOUR_API_KEY